Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Stocks | Futures | Watchlist | More
or

Moderna Inc (MRNA)

Moderna Inc (MRNA)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 58,169,368
  • Shares Outstanding, K 395,710
  • Annual Sales, $ 60,210 K
  • Annual Income, $ -514,020 K
  • 60-Month Beta 1.73
  • Price/Sales 217.93
  • Price/Cash Flow N/A
  • Price/Book 19.07
Trade MRNA with:

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 14 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/20
See More
  • Average Estimate -0.18
  • Number of Estimates 7
  • High Estimate 0.17
  • Low Estimate -0.75
  • Prior Year -0.37
  • Growth Rate Est. (year over year) +51.35%

Price Performance

See More
Period Period Low Period High Performance
1-Month
102.66 +47.99%
on 12/31/20
154.55 -1.70%
on 01/26/21
+28.54 (+23.13%)
since 12/24/20
3-Month
65.49 +131.99%
on 10/28/20
178.50 -14.89%
on 12/01/20
+81.69 (+116.30%)
since 10/26/20
52-Week
17.91 +748.30%
on 02/21/20
178.50 -14.89%
on 12/01/20
+130.81 (+619.37%)
since 01/24/20

Most Recent Stories

More News
Can Moderna ETFs Gain on COVID Vaccine Update Against Variants?

Positive coronavirus vaccine update from Moderna (MRNA) has hogged investors' attention.

MRNA : 151.93 (+3.35%)
IBB : 164.83 (-1.74%)
XBI : 154.38 (-1.76%)
BBH : 186.67 (-1.86%)
BTEC : 64.22 (-1.38%)
GERM : 38.32 (+1.91%)
The Zacks Analyst Blog Highlights: NIKE, Amgen, Morgan Stanley, Vertex Pharma and Moderna

The Zacks Analyst Blog Highlights: NIKE, Amgen, Morgan Stanley, Vertex Pharma and Moderna

NKE : 135.10 (-1.78%)
MS : 71.21 (-1.62%)
MRNA : 151.93 (+3.35%)
AMGN : 258.60 (+0.58%)
VRTX : 237.64 (-1.52%)
How Long Will Coronavirus Vaccine Drive Moderna (MRNA) Stock?

Moderna's (MRNA) progress with coronavirus vaccine development and its approval is driving its share prices for the past year. Will the trend continue?

AZN : 54.44 (+0.80%)
PFE : 37.31 (+0.08%)
MRNA : 151.93 (+3.35%)
BNTX : 106.29 (-3.91%)
Thinking about trading options or stock in Eli Lilly, Apple, Moderna, Workhorse Group, or iRobot?

, /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for LLY, AAPL, MRNA, WKHS, and IRBT.

AAPL : 143.16 (+0.17%)
IRBT : 126.40 (+9.14%)
MRNA : 151.93 (+3.35%)
WKHS : 32.18 (+30.23%)
LLY : 212.72 (+0.17%)
Moderna Provides U.S. COVID-19 Vaccine Supply Update

--Remains on track to deliver 100 million doses to the U.S. Government by end of March 2021

MRNA : 151.93 (+3.35%)
Futures up With Oil Prices

Futures for Canada's main stock index rose on Tuesday as crude oil prices neared 11-month highs on the ...

MRNA : 151.93 (+3.35%)
WestRock, Carnival fall; AMC Entertainment, Moderna rise

NEW YORK (AP) — Stocks that traded heavily or had substantial price changes Monday:

CCL : 18.72 (-2.60%)
AMC : 4.96 (+12.22%)
MRNA : 151.93 (+3.35%)
FFIV : 208.56 (+0.63%)
KMB : 137.13 (+0.45%)
Top Stock Reports for NIKE, Amgen & Morgan Stanley

Top Stock Reports for NIKE, Amgen & Morgan Stanley

VRTX : 237.64 (-1.52%)
NKE : 135.10 (-1.78%)
MS : 71.21 (-1.62%)
MRNA : 151.93 (+3.35%)
DUK : 92.92 (+0.01%)
AMGN : 258.60 (+0.58%)
Moderna to Host Conference Call on COVID-19 Variants Announcement on Monday, Jan. 25

Moderna, Inc., (Nasdaq: MRNA) a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines, today announced that it will hold a conference call today, Monday, January 25 at 4:30 pm...

MRNA : 151.93 (+3.35%)
Pfizer (PFE) to Supply 40M Doses of Coronavirus Vaccine to COVAX

Pfizer (PFE) and BioNTech inks an agreement with COVAX to supply up to 40 million doses of their COVID-19 vaccine, BNT162b2.

AZN : 54.44 (+0.80%)
PFE : 37.31 (+0.08%)
MRNA : 151.93 (+3.35%)
BNTX : 106.29 (-3.91%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 88% Buy with a Strongest short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

The market is in highly overbought territory. Beware of a trend reversal.

See More Share

Business Summary

Moderna Inc. is a clinical stage biotechnology company pioneering messenger RNA therapeutics and vaccines for patients. The company's product pipeline which is in clinical stage consists of mRNA-1647 for Cytomegalovirus Infectious Disease, mRNA-4157 for Solid tumors, mRNA-2416 for lymphoma and mRNA-...

See More

Key Turning Points

3rd Resistance Point 165.54
2nd Resistance Point 160.04
1st Resistance Point 155.99
Last Price 151.93
1st Support Level 146.44
2nd Support Level 140.94
3rd Support Level 136.89

See More

52-Week High 178.50
Last Price 151.93
Fibonacci 61.8% 117.15
Fibonacci 50% 98.21
Fibonacci 38.2% 79.26
52-Week Low 17.91

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar